Article
LAMP2A regulates cisplatin resistance in colorectal cancer through mediating autophagy
8 May 2024
Abstract excerpt
BACKGROUND: Drug resistance is an important constraint on clinical outcomes in advanced cancers. LAMP2A is a limiting protein in molecular chaperone-mediated autophagy. This study was aimed to explore LAMP2A function in cisplatin (cis-diamminedichloroplatinum, DDP) resistance colorectal cancer (CRC) to seek new ideas for CRC clinical treatment. METHODS: In this study, LAMP2A expression was analyzed by molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
